نتائج البحث 1011-1020 من 5028 لعملية البحث عن Blood factor II
... factors that may determine disease progression and treatment response. ... IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases ... We aim to ...
... 2-hydroxyglutarate (2HG) and, therefore ... factors associated with onset of symptoms in MSA. ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct future ...
Patients will complete dietary questionnaire and have research blood ... This is a phase II multi-center study of nab ... The overall goals of this study are to ...
... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also ... factors and spared pathophysiological effects despite their genetic risk.
In this study, some of the patient's T cells will be removed from their blood. ... Factors. Rochester, Minn ... Randomized Phase II/III Trial of Adjuvant ...
Godby, M.D.. Hematologist. Rochester, MN. مناطق التركيز: Blood transfusion, Bone marrow biopsy and aspiration, Immunosuppressive drug therapy, Growth factor ...
The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...
There is very little data exists in regards to patient clinical characteristics, risk factors, treatment and outcomes. Our objective is to prospectively ...
... blood samples for future DNA/RNA sequencing , and to collect patient urine samples for future prostate cancer related biomarker detection and DNA/RNA sequencing ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.